Skip to main content
OpenTrials
Completed

NCT Number: NCT01484899

Smoking: a Risk Factor for Pulmonary Arterial Hypertension?

Environmental factors may play a role in the genesis of pulmonary hypertension, especially in endothelial dysfunction. One widespread environmental factor associated with systemic endothelial dysfunction is cigarette smoke. It may well be that cigarette smoking is not only a risk factor for systemic but also for pulmonary vascular diseases and herewith may interact with other risk factors such as a genetic background and associated conditions. The existing studies which deal with this subject are only small single center case control studies providing less data. Therefore a large European multicenter study is necessary.

The investigators hypothesis are:

* a history of tobacco smoke exposure is highly prevalent in patients with PAH compared to the unaffected general population. * a history of tobacco smoke exposure is more prevalent in patients with PAH compared to CTEPH.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Graz, Graz, Austria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pulmonary artery pressure >25mmHg
  • pulmonary capillary occlusion pressure ≤15mmHg

Exclusion criteria

  • pulmonary artery pressure <25mmHg
  • pulmonary capillary occlusion pressure >15mmHg

Treatment and study plan

Primary outcomes

  1. Difference in Prevalence of Smoking history in patients with PAH compared to unaffected general population

    Time frame: Assessment during outpatient consultation, an expected average of 1 day.

    Patients will be asked with a specific questionnaire concerning their tobacco smoke exposure and smoking history. Control-group: Data from Swiss health survey (SHS) 2007 (Gesundheitsbefragung Schweiz).

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Smoking: a Risk Factor for Pulmonary Arterial Hypertension? A D-A-CH Pulmonary Hypertension Study (Germany- Austria - Switzerland)

Acronym: DACH

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Dec 2, 2011
Registry last updated
Jul 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.